Biogen — Shares rose more than 3% after a new study on Biogen and Eisai’s experimental Alzheimer’s drug showed promising results. Esai also said it believes two deaths in the trial of the drug could not be attributed to the treatment. Biogen stock fell earlier in the week when the report of the second death first surfaced.
Hewlett Packard Enterprise — Shares of Hewlett Packard Enterprise rose more than 4% after the tech company reported beats on the top and bottom lines for the most recent quarter. It also issued strong revenue guidance.
